These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8239542)

  • 21. [Proteomic analysis of mitochondrial proteins in hydroxycamptothecin-treated SMMC-7721 cells].
    Fu YR; Yi ZJ; Yan YR; Qiu ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):572-6. PubMed ID: 17711624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of 10-hydroxycamptothecin on nuclear RNA polymerase activity in hepatoma cells in mice].
    Ling YH; Yu WJ; Xu B
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):211-3. PubMed ID: 6239516
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
    Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
    Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
    Zhao R; al-Said NH; Sternbach DL; Lown JW
    J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclane-aminol 10-hydroxycamptothecin analogs as novel DNA topoisomerase I inhibitors induce apoptosis selectively in tumor cells.
    Zhang S; Geng T; Jiang B; Song G; Ha L; Sun C; Qian Y; Fan Q; Guo H
    Anticancer Drugs; 2014 Jul; 25(6):614-23. PubMed ID: 24525588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT; Bertrand R
    Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
    Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of human hepatoma Hep G2 cells induced by 10-hydroxycamptothecin.
    Zhang X; Zhou Y; Xu B
    Chin Med J (Engl); 2000 Aug; 113(8):712-3. PubMed ID: 11776054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of hydroxycamptothecin and teniposide on proliferation and apoptosis of gastric cancer cell line BGC-823].
    Luo ZF; Zhou Y; Liu MY
    Ai Zheng; 2007 Aug; 26(8):843-5. PubMed ID: 17697544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The synergistic antitumor effects of berberine alpha-hydroxy-beta-decanoylethyl sulfonate with hydroxycamptothecine and its effect on topoisomerase].
    Lin J; Wang X
    Yao Xue Xue Bao; 2011 Apr; 46(4):390-4. PubMed ID: 21751491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of hydroxycamptothecin on colony formation of KB cells and DNA damage].
    Wang XW; Shen ZM; Yang JL; Xu B
    Yao Xue Xue Bao; 1986 Jul; 21(7):492-7. PubMed ID: 3811937
    [No Abstract]   [Full Text] [Related]  

  • 32. Alteration of nuclear matrix protein composition of neuroblastoma cells after arsenic trioxide treatment.
    Wang ZH; Yu D; Li HK; Chow VW; Ng CC; Chan HB; Cheng SB; Chew EC
    Anticancer Res; 2001; 21(1A):493-8. PubMed ID: 11299786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
    Zhao YX; Liu DX; Liang WQ; Ye ZW
    J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the composition of the nuclear matrix proteins of Zajdela hepatoma cells with novobiocin inhibition of DNA replication].
    Kutsyĭ MP; Gaziev AI
    Izv Akad Nauk SSSR Biol; 1987; (4):558-64. PubMed ID: 3668067
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan.
    Danks MK; Garrett KE; Marion RC; Whipple DO
    Cancer Res; 1996 Apr; 56(7):1664-73. PubMed ID: 8603418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and localization of Scl-70/DNA topoisomerase I vary throughout the cell cycle.
    Ramirez-Santoyo R; Lopez-Swiderski A; Avalos-Diaz E; Herrera-Esparza R
    Rev Rhum Engl Ed; 1998 Mar; 65(3):165-72. PubMed ID: 9574473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
    Medema RH; Klompmaker R; Smits VA; Rijksen G
    Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.